Skip to main content

Published locations for ECC: Pembrolizumab hits mark in heavily pretreated nasopharngeal cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ECC: Pembrolizumab hits mark in heavily pretreated nasopharngeal cancer

User login

  • Reset your password
  • /content/ecc-pembrolizumab-hits-mark-heavily-pretreated-nasopharngeal-cancer
  • /oncologypractice/article/103049/head-neck-cancers/ecc-pembrolizumab-hits-mark-heavily-pretreated
  • /hematology-oncology/article/103049/head-neck-cancers/ecc-pembrolizumab-hits-mark-heavily-pretreated